NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Xellar Biosystems

Xellar Biosystems

Private
Boston, MassachusettsHealthcare & Life Scienceshttps://xellarbio.com/

Last Round

Series A

Jun 29, 2026

Total Funding Raised

$60M

Momentum

Top 1%

of companies Caplight tracks

Company Overview

Xellar Biosystems is a biotechnology company that provides an artificial intelligence and organ-on-a-chip platform to accelerate drug discovery and development.

Sector

Healthcare & Life Sciences

Verticals

Drug Discovery, Biotechnology, Medical AI, ML Platforms, Biotech Equipment

Business Model

B2B

Customer Profile

Services & Consulting, Revenue Share, Data as a Service

AI Layer

Application

Keywords

organ-on-a-chipdrug discoverypreclinical testingorgan-on-chipin vitro modelstoxicity assessmentAI drug discoverylab automationmicrofluidicshigh-content imagingoocbiological dataphenotypic analysispredictive modelingdigital twin biologyanimal-free testingvirtual cell

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Xellar Biosystems Comparables

Compare Xellar Biosystems with similar companies based on industry and business-model similarity.

Xellar Biosystems comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Quris AI
89%
Anivance AI
84%
Tissue Dynamics
83%

Xellar Biosystems Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series AJun 29, 2026
StrategicApr 30, 2025
VC RoundJul 17, 2024
AngelAug 30, 2022

Key People

Founding team and executive leadership

Xin Xie

Co-Founder CEO

Founding Team

Xellar Biosystems Investors

Notable investors and investment history

Xellar Biosystems investors
InvestorRounds
China Life Investment Management CompanySeries A
ZhenFundAngel
Zhengxuan InvestmentVC Round
Tiantu CapitalStrategic, VC Round, Series A
Legend CapitalVC Round, Series A, Angel

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jun 29, 2026

    $50M round completed.

  • Jul 17, 2024

    $14M round led by TriApex Laboratories

Xellar Biosystems Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Xellar Biosystems Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Xellar Biosystems's valuation, stock price, and market status.

Firmographic Details

HeadquartersBoston, Massachusetts
Employee Range28
Year Founded2022
Last FundingJun 29, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.